- Home
- PRME vs CRON Comparison
PRME vs CRON Comparison
Compare PRME & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- CRON
- Stock Information
- Founded
- PRME 2019
- CRON N/A
- Country
- PRME United States
- CRON Canada
- Employees
- PRME N/A
- CRON N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- CRON Medicinal Chemicals and Botanical Products
- Sector
- PRME Health Care
- CRON Health Care
- Exchange
- PRME Nasdaq
- CRON Nasdaq
- Market Cap
- PRME 693.5M
- CRON 809.4M
- IPO Year
- PRME 2022
- CRON N/A
- Fundamental
- Price
- PRME $5.78
- CRON $2.64
- Analyst Decision
- PRME Buy
- CRON
- Analyst Count
- PRME 6
- CRON 0
- Target Price
- PRME $8.88
- CRON N/A
- AVG Volume (30 Days)
- PRME 3.8M
- CRON 2.9M
- Earning Date
- PRME 11-11-2025
- CRON 11-11-2025
- Dividend Yield
- PRME N/A
- CRON N/A
- EPS Growth
- PRME N/A
- CRON N/A
- EPS
- PRME N/A
- CRON 0.05
- Revenue
- PRME $4,961,000.00
- CRON $130,282,000.00
- Revenue This Year
- PRME $179.58
- CRON $19.67
- Revenue Next Year
- PRME N/A
- CRON $30.56
- P/E Ratio
- PRME N/A
- CRON $53.06
- Revenue Growth
- PRME 739.42
- CRON 28.01
- 52 Week Low
- PRME $1.11
- CRON $1.60
- 52 Week High
- PRME $6.94
- CRON $3.16
- Technical
- Relative Strength Index (RSI)
- PRME 60.95
- CRON 56.77
- Support Level
- PRME $4.87
- CRON $2.61
- Resistance Level
- PRME $6.94
- CRON $2.76
- Average True Range (ATR)
- PRME 0.49
- CRON 0.09
- MACD
- PRME 0.07
- CRON -0.01
- Stochastic Oscillator
- PRME 47.88
- CRON 53.14
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About CRON Cronos Group Inc. Common Share
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.